Shanghai Henlius Biotech, Inc. Class H Balance Sheet
Shanghai Henlius Biotech, Inc. Class H's total assets for Q2 2025 were ¥11.55B, a decrease of 0.00% from the previous quarter. HK:2696 total liabilities were ¥8.14B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.